Srx Medicine最新文献

筛选
英文 中文
Fatal Mimicry: Oral Melanoma versus Mantle Cell Lymphoma 致命模拟:口腔黑色素瘤与套细胞淋巴瘤
Srx Medicine Pub Date : 2010-03-30 DOI: 10.3814/2010/581923
L. Margolin, A. Monselise
{"title":"Fatal Mimicry: Oral Melanoma versus Mantle Cell Lymphoma","authors":"L. Margolin, A. Monselise","doi":"10.3814/2010/581923","DOIUrl":"https://doi.org/10.3814/2010/581923","url":null,"abstract":"We present a 71-year-old male with oral melanoma and mantle cell hyperplasia who was erroneously diagnosed and treated as mantle cell lymphoma. The differential diagnosis of MCL versus mantle cell hyperplasia is a challenging task. Thorough immunohistochemical and cytogenetic analyses are warranted before treatment administration. The more common presentation of amelanotic malignant melanoma requires a high index of suspicion for masses identified in the mouth and requires biopsy for definitive diagnosis. A meticulous physical examination is advocated.","PeriodicalId":438743,"journal":{"name":"Srx Medicine","volume":"2010 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2010-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130688123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is Absolute Lymphocyte Count Just Another Prognostic Factor in Cancer 绝对淋巴细胞计数是癌症的另一个预后因素吗
Srx Medicine Pub Date : 2010-02-21 DOI: 10.3814/2010/812304
L. Porrata, S. Markovic
{"title":"Is Absolute Lymphocyte Count Just Another Prognostic Factor in Cancer","authors":"L. Porrata, S. Markovic","doi":"10.3814/2010/812304","DOIUrl":"https://doi.org/10.3814/2010/812304","url":null,"abstract":"The role of host immunity in cancer clinical outcomes has been wellestablished in animal models. In humans, the impact of the immune system as a therapeutic maneuver to treat malignancies has been proven by the development of graft-versus-tumor effect observed in the allogeneic stem cell transplantation. However, with few notable exceptions, no definitive conclusions have been reached as to the role of host immunity in humans and its impact on cancer outcomes. This article reviews the clinical evidence of how human immunity can affect cancer clinical outcomes using the absolute lymphocyte count as a surrogate maker of host immune competence.","PeriodicalId":438743,"journal":{"name":"Srx Medicine","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2010-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128239123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Long-Term Effect of Colestimide on Glycemic Control in Patients with Type 2 Diabetes with Elevated Low-Density Lipoprotein Cholesterol Levels Colestimide对低密度脂蛋白胆固醇水平升高的2型糖尿病患者血糖控制的长期影响
Srx Medicine Pub Date : 2010-01-13 DOI: 10.3814/2010/973413
K. Takebayashi, M. Suetsugu, Y. Aso, T. Inukai
{"title":"Long-Term Effect of Colestimide on Glycemic Control in Patients with Type 2 Diabetes with Elevated Low-Density Lipoprotein Cholesterol Levels","authors":"K. Takebayashi, M. Suetsugu, Y. Aso, T. Inukai","doi":"10.3814/2010/973413","DOIUrl":"https://doi.org/10.3814/2010/973413","url":null,"abstract":"Objective. Bile acid sequestrants (BASs) have been shown to improve both low-density lipoprotein-(LDL-) cholesterol and hemoglobin (Hb) A1c levels in patients with type 2 diabetes with elevated LDL levels. However, the longitudinal effect on glycemic control in these patients has not been fully examined. In the current study, the effect of colestimide (a BAS used in Japan, called also as colestilan) over a mean period of 18 months was investigated in patients with type 2 diabetes with elevated LDL levels. \u0000Methods. The study was performed prospectively in 34 patients with type 2 diabetes with elevated LDL levels who started colestimide (3.0 g a day) between April 2007 and March 2008. \u0000Results. HbA1c was significantly decreased after 3 months of colestimide therapy and at the end point of treatment (a mean period of 18 months) compared with baseline values (8.1%±1.1% at baseline, 7.1%±0.7% at 3 months, and 7.2%±0.9% at the end point; both P .05, 3 months versus end point). Colestimide also significantly reduced LDL-C at 3 months and at the end point (both P .05, 3 months versus end point). However, fasting plasma glucose, triglycerides, systolic and diastolic blood pressure, and body weight did not differ significantly after 3 months and at the end point compared with the respective baseline values. \u0000Conclusion. Colestimide significantly decreased HbA1c over a relatively long-term period in patients with type 2 diabetes with elevated LDL levels.","PeriodicalId":438743,"journal":{"name":"Srx Medicine","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2010-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134340172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Amlodipine on Oxidative Stress in Patients with Type 2 Diabetes 氨氯地平对2型糖尿病患者氧化应激的影响
Srx Medicine Pub Date : 2010-01-13 DOI: 10.3814/2010/326840
K. Takebayashi, Rika Naruse, Y. Aso, T. Inukai
{"title":"The Effect of Amlodipine on Oxidative Stress in Patients with Type 2 Diabetes","authors":"K. Takebayashi, Rika Naruse, Y. Aso, T. Inukai","doi":"10.3814/2010/326840","DOIUrl":"https://doi.org/10.3814/2010/326840","url":null,"abstract":"Background. Amlodipine, a calcium channel blocker, is reported to have an antioxidative effect in vitro, but whether such an effect occurs clinically is unknown. The purpose of the study was to investigate the effect of amlodipine (5 mg/day) on oxidative stress by measuring urinary 8-iso-prostaglandin F2α (8-iso-PGF2α), an oxidative stress marker, in patients with type 2 diabetes. The anti-oxidative effect of amlodipine was also assessed using the levels of high-sensitivity C-reactive protein (hsCRP) and fibrinogen. Patients and Methods. Seventeen consecutive patients with type 2 diabetes complicated by hypertension were prospectively enrolled in the study. These patients received amlodipine (5 mg/day) over a 3-month period and various markers were measured before and at the end of this period. Results. Urinary 8-iso-PGF2α showed a tendency to decrease, but the change was not statistically significant (P=.1127). The patients were divided into two groups according to the baseline level of urinary 8-iso-PGF2α, and a significant decrease in 8-iso-PGF2α was found in the group (n=9) with a relatively high baseline 8-iso-PGF2α. There were no changes in hsCRP, fibrinogen, and plasminogen activator inhibitor-1. Significant decreases in systolic and diastolic blood pressure were observed (P<.0001, P=.0151, resp.). Conclusion. The results show that amlodipine (5 mg/day) may provide a clinically useful anti-oxidative effect, based on evaluation of urinary 8-iso-PGF2α.","PeriodicalId":438743,"journal":{"name":"Srx Medicine","volume":"55 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2010-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132798708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Giant Schwannoma with Endoabdominal Development: A Case of Radiculopathy 腹腔内发展的巨大神经鞘瘤:神经根病1例
Srx Medicine Pub Date : 1900-01-01 DOI: 10.3814/2010/975915
N. Morelli, M. Mancuso, C. Tavarelli, S. Gallerini, G. Cafforio, S. Delucchi, D. Guidetti
{"title":"Giant Schwannoma with Endoabdominal Development: A Case of Radiculopathy","authors":"N. Morelli, M. Mancuso, C. Tavarelli, S. Gallerini, G. Cafforio, S. Delucchi, D. Guidetti","doi":"10.3814/2010/975915","DOIUrl":"https://doi.org/10.3814/2010/975915","url":null,"abstract":"Lumbosacral radiculopathy is a very common pathology, frequently caused by degenerative spondyloarthropathies. However, radiculopathy may result from tumor in various locations within the spinal canal, more commonly extramedullary. Primary nerve root tumors are a rare cause of lumbosacral radiculopathy. The majority of primary spinal tumors are benign and slow growing, and their clinical manifestations may be difficult to distinguish from more common causes of radiculopathy, such as a disc herniation. To our knowledge, voluminous schwannomas with endoabdominal development have only rarely been observed. Lumbosacral radiculopathy is a common neurological syndrome which can be an important source of disability. Although the most common causes are disc herniation and chronic spinal arthropathy, physicians should be mindful of other causes, including neoplasms.","PeriodicalId":438743,"journal":{"name":"Srx Medicine","volume":"195 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121245551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书